← Leaderboards
T.-C. Wu
Howard University
$25,440,772
Attributed
$28,640,667
Total exposure
36
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$81,569,164 · 39
By mechanism
P50$63,475,207 · 20
R01$9,481,955 · 6
P01$3,289,767 · 2
U01$1,394,332 · 1
R21$1,237,398 · 3
P20$1,074,374 · 3
Top collaborators
- Drew M. Pardoll10 shared
- Edward E Partridge10 shared
- Cornelia L Trimble10 shared
- Xinbin Gu7 shared
- Ronald D. Alvarez5 shared
- Warner King Huh2 shared
Others in their field
Top investigators on “Malignant Neoplasm Of Cervix Uteri”
- David Heimbrook · Leidos Biomedical Research, Inc.$177,328,706
- Philip J Disaia · University Of California Irvine$75,863,106
- Walter John Curran · Thomas Jefferson University$47,862,860
- Larry Arthur$27,902,757
- Norman Wolmark · Nsabp Foundation, Inc.$21,221,311
- Constantin T Yiannoutsos · Harvard University (Sch Of Public Hlth)$18,414,774
Research focus
Malignant Neoplasm Of Cervix UteriProgramsHuman PapillomavirusFundingResearch PersonnelInnovationUniversitiesMalignant NeoplasmsHuman Papillomavirus 16SafetyVaccinationImmune ResponseTranslational ResearchCommunicationAlabamaVaccinesAnticancer ResearchLesionBaseAntigensDna VaccinesTumorCareer DevelopmentImmunology
Grant awards (170)
SPORE in Cervical Cancer$2,261,467
P50 · FY2025 · CA · contact PI
Strategies to Reduce Global Health Disparities in Cervical Cancer$630,506
R01 · FY2025 · CA · contact PI
Therapeutic HPV vaccines (PVX7) for Advanced Cervical Cancer$294,524
P50 · FY2025 · CA · contact PI
Administration/Communication Core$294,503
P50 · FY2025 · CA · contact PI
Developmental Research Program$150,735
P50 · FY2025 · CA · contact PI
Career Enhancement Program$147,520
P50 · FY2025 · CA · contact PI
Howard University Summer Research Education Experience Program in Oral Health$131,800
R25 · FY2025 · DE
SPORE in Cervical Cancer$1,949,494
P50 · FY2024 · CA · contact PI
Administration/Communication Core$268,351
P50 · FY2024 · CA · contact PI
Therapeutic HPV vaccines (PVX7) for Advanced Cervical Cancer$252,436
P50 · FY2024 · CA · contact PI
Howard University Summer Research Education Experience Program in Oral Health$131,800
R25 · FY2024 · DE
Developmental Research Program$114,399
P50 · FY2024 · CA · contact PI
Career Enhancement Program$111,313
P50 · FY2024 · CA · contact PI
SPORE in Cervical Cancer$1,672,035
P50 · FY2023 · CA · contact PI
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy$570,782
R01 · FY2023 · CA · contact PI
A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection$297,816
P50 · FY2023 · CA · contact PI
Administrative/Communication Core$165,853
P50 · FY2023 · CA · contact PI
Howard University Summer Research Education Experience Program in Oral Health$133,800
R25 · FY2023 · DE
Development Research Program$129,386
P50 · FY2023 · CA · contact PI
Career Enhancement Program$127,845
P50 · FY2023 · CA · contact PI
SPORE in Cervical Cancer$1,669,823
P50 · FY2022 · CA · contact PI
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy$571,193
R01 · FY2022 · CA · contact PI
A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection$362,763
P50 · FY2022 · CA · contact PI
Administrative/Communication Core$200,197
P50 · FY2022 · CA · contact PI
SPORE in Cervical Cancer$199,889
P50 · FY2022 · CA · contact PI
Admin-Core-001$199,889
P50 · FY2022 · CA · contact PI
Development Research Program$159,775
P50 · FY2022 · CA · contact PI
Career Enhancement Program$157,257
P50 · FY2022 · CA · contact PI
SPORE in Cervical Cancer$1,668,414
P50 · FY2021 · CA · contact PI
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy$583,258
R01 · FY2021 · CA · contact PI
Administrative/Communication Core$208,552
P50 · FY2021 · CA · contact PI
Development Research Program$208,551
P50 · FY2021 · CA · contact PI
A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection$208,551
P50 · FY2021 · CA · contact PI
Career Enhancement Program$208,551
P50 · FY2021 · CA · contact PI
SPORE in Cervical Cancer$1,704,839
P50 · FY2020 · CA · contact PI
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy$583,657
R01 · FY2020 · CA · contact PI
A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection$308,365
P50 · FY2020 · CA · contact PI
Administrative/Communication Core$170,312
P50 · FY2020 · CA · contact PI
Development Research Program$135,650
P50 · FY2020 · CA · contact PI
Career Enhancement Program$133,560
P50 · FY2020 · CA · contact PI
Howard University Summer Research Experience Program in Oral Health Disparity for Underrepresented Racial and Ethnic Students$52,663
R25 · FY2020 · DE
SPORE in Cervical Cancer$1,279,343
P50 · FY2019 · CA · contact PI
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy$596,869
R01 · FY2019 · CA · contact PI
A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection$227,541
P50 · FY2019 · CA · contact PI
Administrative/Communication Core$121,796
P50 · FY2019 · CA · contact PI
Development Research Program$104,695
P50 · FY2019 · CA · contact PI
Career Enhancement Program$101,796
P50 · FY2019 · CA · contact PI
Howard University Summer Research Experience Program in Oral Health Disparity for Underrepresented Racial and Ethnic Students$52,823
R25 · FY2019 · DE
SPORE in Cervical Cancer$2,251,770
P50 · FY2018 · CA · contact PI
Ovarian cancer gene therapy using HPV pseudovirion$336,150
R01 · FY2018 · CA · contact PI
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei$249,080
P50 · FY2018 · CA · contact PI
Administration/Communication$246,497
P50 · FY2018 · CA · contact PI
Developmental Research Program$162,903
P50 · FY2018 · CA · contact PI
Career Development Program$161,579
P50 · FY2018 · CA · contact PI
Howard University Summer Research Experience Program in Oral Health Disparity for Underrepresented Racial and Ethnic Students$52,823
R25 · FY2018 · DE
SPORE in Cervical Cancer$2,300,000
P50 · FY2017 · CA · contact PI
Ovarian cancer gene therapy using HPV pseudovirion$336,150
R01 · FY2017 · CA · contact PI
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei$254,559
P50 · FY2017 · CA · contact PI
Administration/Communication$251,905
P50 · FY2017 · CA · contact PI
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research$179,686
P20 · FY2017 · CA · contact PI
Developmental Research Program$166,020
P50 · FY2017 · CA · contact PI
Career Development Program$164,660
P50 · FY2017 · CA · contact PI
Research Pilot Project 1$73,295
P20 · FY2017 · CA · contact PI
Howard University Summer Research Experience Program in Oral Health Disparity for Underrepresented Racial and Ethnic Students$52,823
R25 · FY2017 · DE
SPORE in Cervical Cancer$2,152,942
P50 · FY2016 · CA · contact PI
Ovarian cancer gene therapy using HPV pseudovirion$336,150
R01 · FY2016 · CA · contact PI
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity$303,371
R01 · FY2016 · CA · contact PI
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei$238,256
P50 · FY2016 · CA · contact PI
Administration/Communication$235,776
P50 · FY2016 · CA · contact PI
Immune Evasion by Nanog-Mediated Changes to the Tumor Microenvironment.$211,410
R21 · FY2016 · CA · contact PI
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research$184,939
P20 · FY2016 · CA · contact PI
Developmental Research Program$155,475
P50 · FY2016 · CA · contact PI
Career Development Program$154,202
P50 · FY2016 · CA · contact PI
Research Pilot Project 1$74,544
P20 · FY2016 · CA · contact PI
SPORE in Cervical Cancer$2,174,869
P50 · FY2015 · CA · contact PI
Ovarian cancer gene therapy using HPV pseudovirion$336,150
R01 · FY2015 · CA · contact PI
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity$303,371
R01 · FY2015 · CA · contact PI
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei$240,679
P50 · FY2015 · CA · contact PI
Administration/Communication$238,172
P50 · FY2015 · CA · contact PI
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research$190,237
P20 · FY2015 · CA · contact PI
Immune Evasion by Nanog-Mediated Changes to the Tumor Microenvironment.$176,175
R21 · FY2015 · CA · contact PI
Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance.$176,175
R21 · FY2015 · CA · contact PI
Developmental Research Program$157,065
P50 · FY2015 · CA · contact PI
Career Development Program$155,781
P50 · FY2015 · CA · contact PI
Research Pilot Project 1$77,793
P20 · FY2015 · CA · contact PI
SPORE in Cervical Cancer$2,162,000
P50 · FY2014 · CA · contact PI
Ovarian cancer gene therapy using HPV pseudovirion$336,150
R01 · FY2014 · CA · contact PI
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity$294,269
R01 · FY2014 · CA · contact PI
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei$240,095
P50 · FY2014 · CA · contact PI
Administration/Communication$234,986
P50 · FY2014 · CA · contact PI
Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance.$211,410
R21 · FY2014 · CA · contact PI
Developmental Research Program$158,261
P50 · FY2014 · CA · contact PI
Career Development Program$156,990
P50 · FY2014 · CA · contact PI
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research$146,940
P20 · FY2014 · CA · contact PI
Planning and Priority Setting Phase$146,940
P20 · FY2014 · CA · contact PI
SPORE in Cervical Cancer$2,150,500
P50 · FY2013 · CA · contact PI
A phase I trial to assess the safety and immunogenicity of repeated, cluster part$288,750
P50 · FY2013 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity$285,169
R01 · FY2013 · CA · contact PI
Administrative Core$262,466
P50 · FY2013 · CA · contact PI
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o$193,870
P50 · FY2013 · CA
SPORE in Cervical Cancer$111,720
P50 · FY2013 · CA · contact PI
Career Development Program$93,596
P50 · FY2013 · CA · contact PI
Developmental Research Program$90,831
P50 · FY2013 · CA
SPORE in Cervical Cancer$2,300,000
P50 · FY2012 · CA · contact PI
A phase I trial to assess the safety and immunogenicity of repeated, cluster part$309,265
P50 · FY2012 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity$303,371
R01 · FY2012 · CA · contact PI
Administrative Core$282,370
P50 · FY2012 · CA · contact PI
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o$210,399
P50 · FY2012 · CA
Career Development Program$102,508
P50 · FY2012 · CA · contact PI
Developmental Research Program$99,556
P50 · FY2012 · CA
SPORE in Cervical Cancer$90,231
P50 · FY2012 · CA · contact PI
SPORE in Cervical Cancer$2,185,000
P50 · FY2011 · CA · contact PI
A phase I trial to assess the safety and immunogenicity of repeated, cluster part$305,192
P50 · FY2011 · CA
Administrative Core$280,416
P50 · FY2011 · CA · contact PI
Laser treatment to enhance therapeutic HPV DNA vaccine potency$248,757
R21 · FY2011 · AI · contact PI
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o$208,423
P50 · FY2011 · CA
Career Development Program$103,625
P50 · FY2011 · CA · contact PI
Developmental Research Program$100,715
P50 · FY2011 · CA
SPORE in Cervical Cancer$91,245
P50 · FY2011 · CA · contact PI
SPORE in Cervical Cancer$2,300,000
P50 · FY2010 · CA · contact PI
A phase I trial to assess the safety and immunogenicity of repeated, cluster part$301,914
P50 · FY2010 · CA
Administrative Core$280,712
P50 · FY2010 · CA · contact PI
Laser treatment to enhance therapeutic HPV DNA vaccine potency$213,471
R21 · FY2010 · AI · contact PI
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o$210,262
P50 · FY2010 · CA
Career Development Program$105,593
P50 · FY2010 · CA · contact PI
Developmental Research Program$102,700
P50 · FY2010 · CA
SPORE in Cervical Cancer$2,300,000
P50 · FY2009 · CA · contact PI
Dev. of Optimized/Adjuvanted Smallpox DNA Vaccine (Gene Gun)$528,409
U01 · FY2009 · AI · contact PI
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY$307,116
R01 · FY2009 · CA · contact PI
A phase I trial to assess the safety and immunogenicity of repeated, cluster part$304,161
P50 · FY2009 · CA
Administrative Core$277,611
P50 · FY2009 · CA · contact PI
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES$234,577
U19 · FY2009 · CA · contact PI
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o$212,970
P50 · FY2009 · CA
Career Development Program$108,929
P50 · FY2009 · CA · contact PI
Developmental Research Program$106,022
P50 · FY2009 · CA
SPORE in Cervical Cancer$1,165,045
P50 · FY2008 · CA · contact PI
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY$307,116
R01 · FY2008 · CA · contact PI
Dev. of Optimized/Adjuvanted Smallpox DNA Vaccine (Gene Gun)$283,512
U01 · FY2008 · AI · contact PI
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES$234,484
U19 · FY2008 · CA · contact PI
SPORE in Cervical Cancer$2,412,090
P50 · FY2007 · CA · contact PI
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY$306,882
R01 · FY2007 · CA · contact PI
Dev. of Optimized/Adjuvanted Smallpox DNA Vaccine (Gene Gun)$303,292
U01 · FY2007 · AI · contact PI
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES$238,914
U19 · FY2007 · CA · contact PI
SPORE in Cervical Cancer$2,585,813
P50 · FY2006 · CA · contact PI
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY$315,083
R01 · FY2006 · CA · contact PI
Dev. of Optimized/Adjuvanted Smallpox DNA Vaccine (Gene Gun)$279,119
U01 · FY2006 · AI · contact PI
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES$149,813
U19 · FY2006 · CA · contact PI
SPORE in Cervical Cancer$2,651,995
P50 · FY2005 · CA
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY$321,185
R01 · FY2005 · CA
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES$149,811
U19 · FY2005 · CA
SPORE in Cervical Cancer$2,450,204
P50 · FY2004 · CA
SPORE in Cervical Cancer$196,200
P50 · FY2004 · CA
SPORE in Cervical Cancer$2,500,000
P50 · FY2003 · CA
HUMAN IMMUNE RESPONSES TO HPV VACCINES$759,441
P01 · FY2003 · AI
PREVENTIVE/THERAPEUTIC HPV VACCINE DEVELOPMENT$225,712
R01 · FY2003 · CA
IMMUNO- &ANTIANGIOGENESIS THERAPY IN CERVICAL CANCER$0
P50 · FY2003 · CA
HUMAN IMMUNE RESPONSES TO HPV VACCINES$1,125,221
P01 · FY2002 · AI
PREVENTIVE/THERAPEUTIC HPV VACCINE DEVELOPMENT$219,137
R01 · FY2002 · CA
HER-2/NEU-SPECIFIC PSEUDOVIRION CANCER VACCINES$0
U19 · FY2002 · CA
Characterize E7 specific T cell immune responses for HPV vaccine trials$0
P01 · FY2002 · AI
HUMAN IMMUNE RESPONSES TO HPV VACCINES$715,846
P01 · FY2001 · AI
PREVENTIVE/THERAPEUTIC HPV VACCINE DEVELOPMENT$213,081
R01 · FY2001 · CA
ENHANCEMENT OF HPV16 E6 &E7-SPECIFIC ANTITUMOR IMMUNITY$179,051
R01 · FY2001 · CA
Characterize E7 specific T cell immune responses for HPV vaccine trials$0
P01 · FY2001 · AI
HER-2/NEU-SPECIFIC PSEUDOVIRION CANCER VACCINES$0
U19 · FY2001 · CA
HUMAN IMMUNE RESPONSES TO HPV VACCINES$689,259
P01 · FY2000 · AI
PREVENTIVE/THERAPEUTIC HPV VACCINE DEVELOPMENT$207,189
R01 · FY2000 · CA
ENHANCEMENT OF HPV16 E6 &E7-SPECIFIC ANTITUMOR IMMUNITY$173,837
R01 · FY2000 · CA
Characterize E7 specific T cell immune responses for HPV vaccine trials$0
P01 · FY2000 · AI
HER-2/NEU-SPECIFIC PSEUDOVIRION CANCER VACCINES$0
U19 · FY2000 · CA